Industry Solutions

Life Sciences

Bring therapies to market with efficiency and compliance

Contact us

Overview

Thermometer, stethoscope and other medical instruments

Life Sciences information is often disconnected and stored separately from the processes and transactions it was created to support. This siloed information hinders insights, hurting innovation and efficiency. To accelerate life-saving therapies development, companies need to harmonize and integrate systems and applications to unlock their information’s full potential. 

Key Life Sciences solutions

Lab technician pointing at data on a screen

What makes OpenText different

  • Industry-leading subject matter expertise

    Partner with a team that has more than 25 years of experience transforming and automating Life Sciences processes to improve asset management and information governance.

  • Broad solution portfolio

    Leverage a solution portfolio that utilizes information assets from R&D to commercialization to address today’s trends and prepare for tomorrow’s challenges.

Leaders trust OpenText

Learn how leading Life Sciences organizations lean on OpenText solutions.

See more success stories
CDP logo

Ascentage Pharma meets compliance requirements with OpenText

Learn more
CDP logo

Pharmascience achieves real-time document management

Learn more
CDP logo

Global pharmaceutical company enables document availability anywhere, at any time

Learn more

Life Sciences resources

Why intelligent classification of clinical trial data is so important

Read the blog

Healthcare & Life Sciences blogs

Read the blogs

Driving insights, improving patient outcomes

Read the position paper

From promise to purpose: The AI tipping point in Pharma

View the infographic

Clinical Data Intelligence for Life Sciences

Read the overview

Footnotes

  1. [1] Myers, R., Anderson, M., & Korba, C., Striving to become more patient-centric in Life Sciences, 2020
  2. [2] Agrawal, G., Moss, R., Raschke, R., Wurzer, S., & Xue, J., Stepping up the decentralization of clinical trials, 2021
  3. [3] Nimita Limaye, N., Xiao, L., Dunbrack, L., Vallikkat, M., Townsend, M., Giguashvili, N., & Piai, S., IDC FutureScape: Worldwide Life Sciences 2022 Predictions (2021)
  4. [4] Reichert, M., Webster, K., Stanzl, E., Aptekar, J., Donoghoe, N., & Fleming, F., McKinsey & Company Precision Medicine, 2018
  5. [5] Langhauser, K., Cyber scares, 2021
  6. [6] Shelley, S. Staring down supply chain disruption, 2021